Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 5, 2006, Pages 311-315

  Christoforidis, Athanasios ^a,c   Haritandi, Afroditi ^b   Tsitouridis, Ioannis ^a   Tsatra, Ioanna ^a   Tsantali, Haido ^a   Karyda, Stavroula ^a   Dimitriadis, Athanasios S ^b   Athanassiou Metaxa, Miranda ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Aristotle University of Thessaloniki   (Greece)

Author keywords

thalassemia; Heart; Liver; MRI; Pituitary

Indexed keywords

FERRITIN; IRON;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BIOACCUMULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE; HUMAN; HUMAN TISSUE; HYPOPHYSIS; IRON BLOOD LEVEL; LINEAR REGRESSION ANALYSIS; LIVER; LIVER BIOPSY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUBERTY; STATISTICAL SIGNIFICANCE; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; AGE FACTORS; BETA-THALASSEMIA; CHILD; FEMALE; HOMOZYGOTE; HUMANS; IRON; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; PITUITARY GLAND; TISSUE DISTRIBUTION;

EID: 33745241709     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000212915.22265.3b     Document Type: Article

References (23)

1. Weatherall DJ. Pathophysiology of thalassaemia. Baillieres Clin Haematol. 1998;11:127-146.
2. Cunningham MJ, Nathan DG. New developments in iron chelators. Curr Opin Hematol. 2005;12:129-134.
3. Brittenham GM, Badman DG. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop. Noninvasive measurement of iron: report of an NIDDK workshop. Blood. 2003;101:15-19.
4. Jensen PD. Evaluation of iron overload. Br J Haematol. 2004;124:697-711.
5. Cohen A. Management of iron overload in the pediatric patient. Hematol Oncol Clin North Am. 1987;1:521-544.
6. Angelucci E, Muretto P, Nicolucci A, et al. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood. 2002;100:17-21.
7. Johnston DL, Rice L, Vick GW III, et al. Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med. 1989;87:40-47.
8. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005;106:1460-1465.
9. Chan YL, Li CK, Lam CW, et al. Liver iron estimation in beta-thalassaemia: comparison of MRI biochemical assay and histological grading. Clin Radiol. 2001;56:911-916.
10. Bonetti MG, Castriota-Scanderbeg A, Criconia GM, et al. Hepatic iron overload in thalassemic patients: proposal and validation of an MRI method of assessment. Pediatr Radiol. 1996;26:650-656.
11. Mavrogeni SI, Markussis V, Kaklamanis L, et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol. 2005;75:241-247.
12. Cohen AR, Galanello R, Pennell DJ, et al. Thalassemia. Hematol (Am Soc Hematol Educ Program). 2004:14-34.
13. Gatter KC, Brown G, Trowbridge IS, et al. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol. 1983;36:539-545.
14. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171-2179.
15. Argyropoulou MI, Kiortsis DN, Efremidis SC. MRI of the liver and the pituitary gland in patients with beta-thalassemia major: does hepatic siderosis predict pituitary iron deposition? Eur Radiol. 2003;13:12-16.
16. Kushner JP, Porter JP, Olivieri NF. Secondary iron overload. Hematol (Am Soc Hematol Educ Program). 2001:47-61.
17. Atkin SL, Burnett HE, Green VL, et al. Expression of the transferrin receptor in human anterior pituitary adenomas is confined to gonadotrophinomas. Clin Endocrinol (Oxford). 1996;44:467-471.
18. Bergeron C, Kovacs K. Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study. Am J Pathol. 1978;93:295-309.
19. Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian working group on endocrine complications in non-endocrine diseases. Clin Endocrinol (Oxford). 1995;42:581-586.
20. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89:739-761.
21. Sparacia G, Iaia A, Banco A, et al. Transfusional hemochromatosis: quantitative relation of MR imaging pituitary signal intensity reduction to hypogonadotropic hypogonadism. Radiology. 2000;215:818-823.
22. Voskaridou E, Douskou M, Terpos E, et al. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol. 2004;126:736-742.
23. Wood JC, Tyszka JM, Carson S, et al. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood. 2004;103:1934-1936.